Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
Background: In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hyperstimulation syndrome (OHSS). Metformin reduces the risk of OHSS but little is kn...
Guardado en:
Autores principales: | Elia, E.M., Quintana, R., Carrere, C., Bazzano, M.V., Rey-Valzacchi, G., Paz, D.A., Pustovrh, M.C. |
---|---|
Formato: | Artículo publishedVersion |
Lenguaje: | Inglés |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_17572215_v6_n1_p_Elia |
Aporte de: |
Ejemplares similares
-
Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, E.M., et al.
Publicado: (2013) -
Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, E.M., et al. -
Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, Evelin Mariel, et al.
Publicado: (2013) -
Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
por: Yovanovich, Carola Anabel Mariana, et al.
Publicado: (2008) -
Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
por: Quintana, R., et al.